Application 200998
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 200MG | No | No |
| 002 | MEPROBAMATE | MEPROBAMATE | TABLET;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A200998-001 | MEPROBAMATE | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | ||
| A200998-002 | MEPROBAMATE | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200998-001 | MEPROBAMATE | 200MG | TABLET / ORAL | 2011-05-23 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A200998-002 | MEPROBAMATE | 400MG | TABLET / ORAL | 2011-05-23 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meprobamate | MEPROBAMATE | Cipla USA Inc. | 17d814e2-b277-4dce-8615-e7fd7cab773f | 2026-07-08 | Warnings, Adverse reactions | Meprobamate MEPROBAMATE |
| MEPROBAMATE | MEPROBAMATE | Alembic Pharmaceuticals Limited | a0891a32-105b-48bc-a246-5e179d2e7fa1 | 2023-01-10 | Warnings, Adverse reactions | MEPROBAMATE MEPROBAMATE |
| Meprobamate | MEPROBAMATE | Alembic Pharmaceuticals Inc. | 3b255bcd-0218-44f8-830b-971f5ec45276 | 2021-10-01 | Warnings, Adverse reactions | Meprobamate MEPROBAMATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-4147 | Meprobamate | Meprobamate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4148 | Meprobamate | Meprobamate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 52549-4147 | Meprobamate | Meprobamate | Taro Pharmaceutical Industries Ltd. | ANDA | Current |
| 52549-4148 | Meprobamate | Meprobamate | Taro Pharmaceutical Industries Ltd. | ANDA | Current |